Elixxer Past Earnings Performance
Past criteria checks 0/6
Elixxer has been growing earnings at an average annual rate of 4.3%, while the Capital Markets industry saw earnings growing at 12.1% annually. Revenues have been declining at an average rate of 13.9% per year.
Key information
4.3%
Earnings growth rate
23.5%
EPS growth rate
Capital Markets Industry Growth | 12.1% |
Revenue growth rate | -13.9% |
Return on equity | -182.2% |
Net Margin | n/a |
Last Earnings Update | 31 Mar 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Elixxer makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 22 | 0 | -9 | 2 | 0 |
31 Dec 21 | 0 | -4 | 2 | 0 |
30 Sep 21 | 0 | -9 | 5 | 0 |
30 Jun 21 | 0 | 0 | 5 | 0 |
31 Mar 21 | 0 | -5 | 5 | 0 |
31 Dec 20 | 0 | -10 | 5 | 0 |
30 Sep 20 | 0 | -11 | 6 | 0 |
30 Jun 20 | 0 | -15 | 7 | 0 |
31 Mar 20 | 0 | -19 | 9 | 0 |
31 Dec 19 | 0 | -19 | 9 | 0 |
30 Sep 19 | 0 | -13 | 8 | 0 |
30 Jun 19 | 0 | -11 | 4 | 0 |
31 Mar 19 | 0 | -16 | 11 | 0 |
31 Dec 18 | 0 | -14 | 11 | 0 |
30 Sep 18 | 0 | -17 | 14 | 0 |
30 Jun 18 | 0 | -19 | 17 | 0 |
31 Mar 18 | 0 | -9 | 8 | 0 |
31 Dec 17 | 0 | -9 | 7 | 0 |
30 Sep 17 | 0 | -5 | 3 | 0 |
30 Jun 17 | 0 | -5 | 2 | 0 |
31 Mar 17 | 0 | -6 | 3 | 0 |
31 Dec 16 | 0 | -6 | 3 | 0 |
30 Sep 16 | 0 | -8 | 4 | 0 |
Quality Earnings: ELXR is currently unprofitable.
Growing Profit Margin: ELXR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ELXR is unprofitable, but has reduced losses over the past 5 years at a rate of 4.3% per year.
Accelerating Growth: Unable to compare ELXR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ELXR is unprofitable, making it difficult to compare its past year earnings growth to the Capital Markets industry (-7.1%).
Return on Equity
High ROE: ELXR has a negative Return on Equity (-182.25%), as it is currently unprofitable.